Search Result "Incretin mimetics"
GLP-1, Incretin Mimetics and DPP 4 Inhibitors: New Ways in the Treatment of Type 2 Diabetes
Journal: Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume: 5 Issue: 6 Year: 2005 Page: 485-497
Author(s): Juris J. Meier, Michael A. Nauck
Emerging Incretin-Based Therapies for Type 2 Diabetes: Incretin Mimetics and DPP-4 Inhibitors
Journal: Current Diabetes Reviews
Volume: 4 Issue: 2 Year: 2008 Page: 101-109
Author(s): Anthony Stonehouse, Ted Okerson, David Kendall, David Maggs
Incretin-Based Therapy of Type 2 Diabetes Mellitus
Journal: Current Protein & Peptide Science
Volume: 10 Issue: 1 Year: 2009 Page: 46-55
Author(s): Filip K. Knop, Tina Vilsboll, Jens J. Holst
Incretin Pharmacology: A Review of the Incretin Effect and Current Incretin-Based Therapies
Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 10 Issue: 4 Year: 2012 Page: 276-288
Author(s): Joshua J. Neumiller
Incretins and Preservation of Endothelial Function
Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 10 Issue: 4 Year: 2012 Page: 295-308
Author(s): Juraj Koska
Incretins Yesterday, Pleiotropic Gastrointestinal Hormones Today:Glucagon-Like Peptide-1 (GLP-1) and Glucose-ependent Insulinotropic Polypeptide (GIP)
Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Volume: 5 Issue: 3 Year: 2011 Page: 176-182
Author(s): Malgorzata E. Kiec-Klimczak, Dorota M. Pach, Magdalena E. Pogwizd, Alicja B. Hubalewska-Dydejczyk
Benefits of GLP-1 Mimetics on Epicardial Adiposity
Journal: Current Medicinal Chemistry
Volume: 30 Issue: 37 Year: 2023 Page: 4256-4265
Author(s): Fatima C. Stanford
Mechanisms of Incretin Effects on Plasma Lipids and Implications for the Cardiovascular System
Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 10 Issue: 4 Year: 2012 Page: 289-294
Author(s): Changting Xiao,Satya Dash,Gary F. Lewis
Incretin-Based Therapies in Patients with Type 2 Diabetes
Journal: Current Drug Therapy
Volume: 5 Issue: 2 Year: 2010 Page: 75-85
Author(s): Jeffrey S. Freeman, DO
Incretin-Based Antidiabetic Agents for the Management of Non-Alcoholic Fatty Liver Disease
Journal: Current Vascular Pharmacology
Volume: 13 Issue: 5 Year: 2015 Page: 649-657
Author(s): Theodora Nakouti, Apostolos K.A. Karagiannis, Konstantinos Tziomalos, Evangelos Cholongitas